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Abstract – The aging process is associated with a decline in physiological functions, 
including a reduction in muscle quality, as well as changes in cardiometabolic risk 
factors. Thus, the aim of this study was to verify if a correlation exists between muscle 
strength and quality and cardiometabolic risk markers in older women.	Thirty older 
women (66.13±5.26 years, 67.33±12.45 kg, 1.54±0.07 m, body mass index: 28.20±4.72) 
were submitted to the evaluation of muscle thickness and strength and blood analy-
sis of cardiometabolic risk markers (glucose, basal insulin, C-reactive protein, total 
cholesterol, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and 
HOMA-IR). No	significant correlations were found between muscle phenotypes and 
markers of cardiometabolic risk, even after adjustment for confounding factors.	The 
present study indicates that muscle strength or quality is not correlated with markers 
of cardiometabolic risk. 
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Resumo – O processo de envelhecimento está associado a um declínio nas funções fi-
siológicas, refletindo em reduções na qualidade muscular, bem como em alterações de 
marcadores de risco cardiometabólico. Nesse sentido, o objetivo do estudo foi verificar a 
associação entre qualidade muscular e marcadores de risco cardiometabólico em mulheres 
idosas.	Trinta mulheres idosas (66,13±5,26 anos, 67,33±12,45 kg, 1,54±0,07 m, 28,20±4,72 
IMC) foram submetidas à avaliação da espessura e força musculares do quadríceps, e 
à análise sanguínea de marcadores de risco cardiometabólico (glicemia, insulina basal, 
proteína C-reativa, colesterol total, HDL-colesterol, LDL-colesterol, VLDL-colesterol, 
triglicerídeos, e índice HOMA-IR).	Não foram encontradas correlações significativas entre 
os fenótipos musculares e os marcadores de risco cardiometabólico estudados, mesmo 
com controle para fatores de confusão.	A presente pesquisa indica não haver correlação 
entre força e qualidade muscular com os marcadores de risco cardiometabólico estudados.
Palavras-chave: Fatores de risco; Força muscular; Idoso.
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INTRODUCTION
The process of aging is accompanied by different physiological changes 
that affect the function of organs and tissues, with an impact on the inde-
pendence of older adults in activities of daily living and on their functional 
capacity1. Among these changes, the reduction in strength levels and muscle 
mass (i.e., sarcopenia) is negatively associated with the health of older adults, 
including the occurrence of chronic-degenerative diseases2 and a higher 
risk of mortality3, in addition to a significant impact on healthcare costs4. 
Aging has also been associated with an increase in the circulating 
levels of inflammatory markers5 and insulin resistance6 and with a reduc-
tion in cholesterol and its subfractions7. Furthermore, studies have shown 
a relationship between these variables and muscle strength8-10. However, 
this association is not well documented for muscle quality (MQ). Muscle 
quality, also known as specific tension or strength, can be characterized 
as the ratio between maximal muscle strength and muscle mass and is a 
more representative parameter of muscle function than muscle strength or 
muscle mass alone11. As observed for muscle strength and mass, changes 
in MQ can occur during aging12.
In the few studies investigating the association between MQ and mark-
ers of cardiometabolic risk, only variables related to glycemic control were 
analyzed13,14 and the results, methods used for strength evaluation and 
calculation of MQ differed between studies. Furthermore, there are no 
studies analyzing the association between MQ and inflammatory markers 
or lipid profile variables.
One may speculate that the correlation of these variables with MQ is 
more pronounced than with muscle strength since the former is a more 
representative measure of the function of the muscle complex. The identifi-
cation of this correlation is particularly important for the elderly population 
because of the deleterious effects of aging on both the muscle system12 and 
on the levels of some cardiometabolic risk markers5,6. The study of muscle 
phenotypes and blood variables related to cardiometabolic risk in older 
women is of special interest since women are at higher cardiovascular 
risk after the age of 60 years15 and present elevated cholesterol levels7 and 
a higher incidence of diabetes16 when compared to men. 
In this respect, the establishment of a relationship between MQ and 
metabolic variables may contribute to clinical evaluation and to the iden-
tification of inflammatory conditions, alterations in glycemic control and 
other situations of increased cardiometabolic risk. Furthermore, the iden-
tification of these conditions can assist non-pharmacological interventions 
through systematic physical activities in the population studied. Therefore, 
the objective of the present study was to determine the association between 
MQ and markers of cardiometabolic risk in older women. The following 
cardiometabolic risk factors were analyzed: fasting glucose, basal insulin, 
homeostasis model assessment of insulin resistance (HOMA-IR), total 
cholesterol and subfractions, C-reactive protein (CRP), and triglycerides.
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METHODS
Sample
Thirty older women (66.13±5.26 years, 67.33±12.45 kg, 1.54±0.07 m, body 
mass index [BMI] of 28.20±4.72 kg/m2 without any experience in strength 
training were selected to participate in the study. For recruitment of the 
sample, the study was previously published at strategical sites of the 
Federal District through print (banners, billboards and leaflets) and 
interactive media (radio and television). Older women aged 60 to 80 
years who voluntarily agreed to participate in the study were selected. 
After initial recruitment, the following exclusion criteria were applied: 
experience in strength training or participation in a guided physical 
exercise program in the 3 months preceding the evaluations and a his-
tory of musculoskeletal injury related to movements in strength tests.
All subjects were informed about the risks and benefits of the study and 
signed the free informed consent form before participation in the study. 
The study was conducted by the analysis of data originating from initial 
assessments of a sample of subjects participating in a more comprehensive 
study approved by the Ethics Committee on Human Research of the School 
of Health Sciences, University of Brasília (Universidade de Brasília - UnB) 
(Registration No. 001/13).
Experimental procedures
Data were collected on two days at an interval of up to 2 weeks. The first visit 
consisted of anthropometric evaluation and application of a questionnaire 
containing traditional anamnesis data, sociodemographic data, medical 
history, and use of medications. The second visit consisted of blood col-
lection (after a fast of ~12 hours) and the evaluation of muscle thickness 
and isokinetic peak torque. During the second visit, the cited order of 
evaluations was rigorously followed, i.e., immediately after blood collec-
tion the volunteers were invited to have breakfast offered free of charge by 
the Exercise Physiology and Health Research Group, School of Physical 
Education, UnB. Muscle thickness was analyzed after a postprandial period 
of 30 minutes by ultrasonography and muscle strength was then evaluated 
with an isokinetic dynamometer.
Anthropometric assessment
For anthropometric assessment, the subjects were weighed on a digital scale 
to the nearest 50 g and height was measured with a wall stadiometer. The 
BMI was calculated by dividing body weight by the square of the height 
(kg/m2) of the volunteers.
Muscle thickness
Rectus femoris muscle thickness was evaluated by ultrasonography (Philips, 
VMI, Indústria e Comércio Ltda. Lagoa Santa, MG, Brazil). Water-soluble 
gel was applied at the site of measurement and a 7.5-MHz transducer was 
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positioned perpendicularly to the muscle analyzed. The transducer was held 
by the hand of the examiner at a distance of 30 cm from its base and no 
additional pressure was applied to standardize the compression generated 
on the skin. Once the examiner found a satisfactory image, it was frozen 
and stored. Finally, all measurements and analyses were performed three 
times by the same examiner and the mean value was considered for analysis. 
The cut-off value for the evaluation of rectus femoris muscle thickness was 
defined according to Chilibeck et al.17.
Isokinetic peak torque
Isokinetic peak torque (PT) of the knee extensor was measured with an 
isokinetic dynamometer (Biodex System III, Biodex Medical Systems, New 
York, USA). For warm-up and familiarization with the test, the volunteers 
underwent two series of eight repetitions at an angular velocity of 300°.s-1. 
The subjects were asked to exercise at submaximal force levels. Next, PT 
was evaluated after four series of 4 maximal repetitions, the first two per-
formed at 60º.s-1 and the last two at 180°.s-1, with an interval of 1 minute 
between series. Only the PT at 60º.s-1 was considered for analysis and the 
highest value obtained in the two series was used. 
The subjects were positioned comfortably on the dynamometer, which 
was adjusted individually for each subject. After adjustment, the subjects 
were strapped to minimize movements that could interfere with the re-
sults of the tests. The PT values were adjusted for gravity using the Biodex 
Advantage software. It should be noted that older women do not show 
differences in PT between the dominant and non-dominant limb18. Thus, 
only the dominant lower limb was evaluated during the strength test, in 
which all subjects received visual feedback and verbal encouragement.
Muscle quality
Muscle quality, also called specific torque, was defined as the force pro-
duced per unit of muscle volume. The quadriceps muscle was chosen for 
this analysis because it is widely evaluated in older adults and an asso-
ciation with activities of daily living has been well documented. Muscle 
quality was calculated from the measurements of muscle volume and the 
force produced by the muscle. Techniques that are well described in the 
literature were used for the measurements (i.e., isokinetic dynamography 
and ultrasonography)11,14. Thus, muscle strength (isokinetic PT at 60º.s-1) 
was divided by muscle thickness and the results are expressed as N.m/mm.
Blood markers of cardiometabolic risk
Blood was collected after an overnight fast of 12 hours. The samples were 
immediately sent for laboratory analysis of glucose levels, CRP, lipid pro-
file, and insulin. Triglycerides, total cholesterol and its subfractions and 
glucose levels were measured using a colorimetric enzymatic method in the 
Autohumalyzer A5 (Human-2004). Insulin was assayed using the ACS-180 
Chemiluminescence System (Ciba-Corning Diagnostic Corp., 1995, USA). 
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C-reactive protein was measured by a turbidimetric method. Additionally, 
the HOMA-IR was calculated by dividing the product of insulin (μIU/mL) 
and glucose (mmol/dL) by 405.
Statistical analysis
The descriptive characteristics are expressed as the mean and standard 
deviation. Normality of the sample was verified using the Shapiro-Wilk 
test. The association between variables was then evaluated by partial cor-
relation analysis controlling for the following variables: smoking, hormone 
replacement therapy, diseases, medications, and regular physical activity. A 
level of significance of p < 0.05 was adopted. All analyses were performed 
using the SPSS 20.0 software.
RESULTS
The characteristics of the subjects are shown in Table 1.
Table 1. Characteristics of the subjects (n = 30).
Variable Mean ± standard deviation
Age (years)  66.13 ± 5.26
Body weight (kg)  67.33 ± 12.45
Height (m)  1.54 ± 0.07
BMI (kg/m2)  28.20 ± 4.72
Muscle thickness (mm) 29.50 ± 7.36
Peak torque (60º.s-1) (N.m) 86.60 ± 23.12
Muscle quality (N.m/mm) 2.99 ± 0.63
Glucose (mg/dL) 91.87 ± 23.69
Basal insulin (µIU/mL) 11.04 ± 6.82
CRP (mg/dL) 0.27 ± 0.34
Total cholesterol (mg/dL) 189.20 ± 40.85
HDL-c (mg/dL) 50.33 ± 8.81
LDL-c (mg/dL) 116.57 ± 38.21
VLDL-c (mg/dL) 22.30 ± 7.88
Triglycerides (mg/dL)  112.73 ± 39.63
HOMA-IR  2.77 ± 2.36
BMI = body mass index; CRP = C-reactive protein; HDL-c = HDL cholesterol; LDL-c = LDL cholesterol; VLDL-c = 
VLDL cholesterol; HOMA-IR = homeostasis model assessment of insulin resistance.
Analysis of the correlation of muscle strength and MQ with cardio-
metabolic risk markers is shown in Table 2. No significant associations were 
observed between strength or MQ and the cardiometabolic risk markers 
studied. The frequency of the confounding variables was as follows: smoking 
(1 = yes; 29 = no); hormone replacement therapy (2 = yes; 28 = no); diseases 
(27 = yes; 3 = no); use of some medication (27 = yes; 3 = no), and regular 
physical activity (17 = yes; 13 = no). Separate statistical analysis showed 
that adjustment for the variables cited did not alter the results observed. 
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Table 2. Partial correlation of peak torque and muscle quality with markers of cardiometabolic risk.
Variable
PT (60 º.s-1) MQ (N.m/mm)
r p r p
Glucose (mg/dL) 0.243 0.252 0.215 0.314
Basal insulin (µUI/mL) 0.379 0.068 0.284 0.178
CRP (mg/dL) -0.268 0.206 -0.230 0.280
Total cholesterol (mg/dL) 0.239 0.260 -0.243 0.253
HDL-c (mg/dL) 0.069 0.748 -0.171 0.423
LDL-c (mg/dL) 0.184 0.390 -0.261 0.217
VLDL-c (mg/dL) 0.215 0.314 0.191 0.370
Triglycerides (mg/dL) 0.204 0.339 0.156 0.465
HOMA-IR 0.364 0.080 0.282 0.182
PT = peak torque; MQ = muscle quality; CRP = C-reactive protein; HDL-c = HDL cholesterol; LDL-c = LDL cholesterol; 
VLDL-c = VLDL cholesterol; HOMA-IR = homeostasis model assessment of insulin resistance. Values adjusted for the 
following variables: smoking, hormone replacement therapy, diseases, medications, and regular physical activity.
DISCUSSION
The present results did not show significant correlations between strength 
or MQ and cardiometabolic risk markers in older women, even after adjust-
ment for possible confounding variables (smoking, hormone replacement 
therapy, diseases, medications, and regular physical activity). There is spe-
cial interest in studying this association in older women who are at higher 
cardiovascular risk after the age of 60 years15 and who present elevated cho-
lesterol levels7 and a higher incidence of diabetes16 when compared to men. 
Although the muscle phenotypes studied were not significantly 
correlated with glucose (r = 0.243 for strength; r = 0.215 for MQ), basal 
insulin (r = 0.379 for strength; r = 0.284 for MQ) or insulin resistance (r = 
0.364 for strength; r = 0.282 for MQ), there is interest in the study of the 
relationship between these phenotypes and markers of glucose uptake 
since skeletal muscle is the main site of glucose uptake in the body19. 
The question is particularly interesting for the elderly population since 
an increase in insulin resistance6, which indicates the possibility of im-
paired glucose uptake, is one of the metabolic disorders that accompany 
the process of aging. In fact, there is evidence indicating a relationship 
between sarcopenia and increased insulin resistance20.
No significant correlations were observed between muscle strength 
and glucose levels, in agreement with the study of Wijndaele et al.10. 
In contrast to the present results, several studies8,13,14,21,22 have demon-
strated associations between strength and indicators of glycemic control. 
With respect to glucose levels, Jurca et al.8 found an inverse correlation 
between muscle strength and glucose levels in 8,570 men. For insulin 
resistance, Nomura et al.22 reported inverse correlations of lower limb 
strength with insulin levels and HOMA-IR, in agreement with the study 
of Barzilay et al.21. The divergences between the present study and the 
articles cited may be explained by differences in the variables studied 
and in the methods used for muscle strength assessment in those studies.
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The lack of a correlation between MQ and markers of glycemic con-
trol agrees in part with the study of Park et al.14, but is not supported by 
previous studies13,21,23. Park et al.14 observed no significant correlation 
between MQ and glycemic control. These authors also identified a nega-
tive correlation between the duration of diabetes and MQ, although the 
effect of diabetes on MQ was eliminated after adjusting for confounding 
factors in the female population, in agreement with the findings of the 
present study. In contrast, Volpato et al.23 found diabetes to be associated 
with poor MQ in older adults, even after adjustment for age and gender. 
In agreement with these findings, Lee et al.13 observed significant cor-
relations between MQ and insulin sensitivity in 40 obese adolescents. 
Similar results have been reported by Barzilay et al.21. It should be noted 
that the studies cited used different methods for the evaluation of muscle 
strength and thickness, with a direct influence on the values used for the 
calculation of MQ. The lack of standardization in the choice of these vari-
ables may have interfered with the results and their interpretation, as well 
as with the comparisons between previous studies and the present one. 
The lack of a correlation between muscle strength and lipid profile 
(total cholesterol, r = 0.239; HDL-c, r = 0.069; LDL-c, r = 0.184; VLDL-c, r 
= 0.215; triglycerides, r = 0.204) agrees with previous studies22,24, although 
not all have corroborated these findings8,10. Kohl et al.24 compared the 
relationship between muscle strength and lipid profile in men and women 
and found no significant correlations for women. These results are sup-
ported by the study of Nomura et al.22 who also observed no correlations 
between strength and LDL-c, HDL-c or triglycerides, as demonstrated 
in the present study. In contrast, Wijndaele et al.10 found a negative 
correlation between muscle strength and triglycerides and a positive 
correlation between muscle strength and HDL-c in women, correlations 
corroborated by Jurca et al.8, but not observed in the present study. 
Intramuscular fat content is known to be higher in older adults when 
compared to younger individuals25, a fact that may explain the reduc-
tion in MQ observed during aging12. However, although intramuscular 
fat is associated with the availability of circulating lipids26, no significant 
correlations were observed between MQ and lipid profile variables (total 
cholesterol, r = -0.243; HDL-c, r = -0.171; LDL-c, r = -0.261; VLDL-c, r 
= 0.191; triglycerides, r = 0.156). To our knowledge, this is the first study 
investigating this association since we found no studies in the literature 
correlating MQ with triglyceride or cholesterol levels. Methodological dif-
ferences compared to other studies may explain in part the results found.
There was no significant correlation between muscle strength and CRP 
levels (r = -0.268). The findings of the present study agree in part with the 
results reported by Schaap et al.9 who observed no association between 
CRP levels and the relative loss of muscle strength over a period of 3 
years in a study including men and women, although elevated CRP levels 
were found to increase the risk of muscle strength loss in this population. 
However, there is evidence indicating an association between muscle 
Rev Bras Cineantropom Desempenho Hum 2015, 17(2):186-194 193
strength and inflammatory markers27-29, in contrast to the results of the 
present study. In fact, studies suggest that high levels of inflammatory 
proteins are related to catabolic processes in muscle tissue that lead to the 
loss of muscle strength and muscle mass - consequently accelerating the 
process of sarcopenia – and to functional limitations in older adults29,30. 
However, such association was not observed in the present study.
No correlation between MQ and CRP levels was observed in the present 
study (r = -0.230). This finding was expected since MQ is a more functional 
measure of muscle capacity. It was not possible to identify the reason for 
the lack of correlation between these variables, a fact indicating the need 
for further studies with similar objectives. Additionally, there are no 
studies in the literature evaluating the association between MQ and CRP. 
The lack of standardization observed for the calculation of MQ impairs 
comparisons with the results of other studies and is a potential limita-
tion of this study. In fact, there is no consensus in the literature regard-
ing the measurement of MQ. Well-described techniques (i.e., isokinetic 
dynamometry and ultrasonography) were used in the present study11,14.
In summary, no significant correlations were observed between mus-
cle strength or MQ and markers of cardiometabolic risk in older women.
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